DK3299030T3 - Parenterale norovirus-vaccineformuleringer - Google Patents

Parenterale norovirus-vaccineformuleringer Download PDF

Info

Publication number: DK3299030T3
Authority: DK; Denmark
Prior art keywords: vaccine formulations; norovirus vaccine; parenteral; parenteral norovirus; formulations
Prior art date: 2011-07-11

Application number

DK17199372.8T

Other languages

English (en)

Inventor

Charles Richardson

Robert F Bargatze

Paul M Mendelman

Original Assignee

Takeda Vaccines Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-07-11

Filing date

2012-07-11

Publication date

2022-09-05

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47506489&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3299030(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2012-07-11 Application filed by Takeda Vaccines Inc filed Critical Takeda Vaccines Inc

2022-09-05 Application granted granted Critical

2022-09-05 Publication of DK3299030T3 publication Critical patent/DK3299030T3/da

Links

241001263478 Norovirus Species 0.000 title 1
239000000203 mixture Substances 0.000 title 1
229960005486 vaccine Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/16011—Caliciviridae
- C12N2770/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
Epidemiology (AREA)
Microbiology (AREA)
Mycology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicinal Preparation (AREA)

DK17199372.8T 2011-07-11 2012-07-11 Parenterale norovirus-vaccineformuleringer DK3299030T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201161506447P	2011-07-11	2011-07-11
EP12811916.1A EP2731621B1 (en)	2011-07-11	2012-07-11	Parenteral norovirus vaccine formulations

Publications (1)

Publication Number	Publication Date
DK3299030T3 true DK3299030T3 (da)	2022-09-05

Family

ID=47506489

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK17199372.8T DK3299030T3 (da)	2011-07-11	2012-07-11	Parenterale norovirus-vaccineformuleringer

Country Status (29)

Country	Link
US (5)	US9801934B2 (da)
EP (3)	EP4112074A1 (da)
JP (2)	JP6208659B2 (da)
KR (1)	KR102096937B1 (da)
CN (3)	CN108567975A (da)
AU (2)	AU2012282658B2 (da)
BR (1)	BR112014000656A2 (da)
CA (1)	CA2841356C (da)
CL (1)	CL2014000082A1 (da)
CR (2)	CR20190540A (da)
DK (1)	DK3299030T3 (da)
DO (2)	DOP2014000004A (da)
EA (3)	EA029470B1 (da)
EC (1)	ECSP14013201A (da)
ES (2)	ES2656527T3 (da)
GE (1)	GEP201706668B (da)
HK (2)	HK1199202A1 (da)
IL (1)	IL230356B (da)
MA (1)	MA35414B1 (da)
MX (2)	MX379496B (da)
MY (1)	MY170746A (da)
PE (1)	PE20140845A1 (da)
PH (3)	PH12021551773A1 (da)
PL (2)	PL3299030T3 (da)
SG (1)	SG10201605644WA (da)
TN (1)	TN2014000008A1 (da)
UA (1)	UA117732C2 (da)
WO (1)	WO2013009849A1 (da)
ZA (2)	ZA201401012B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2008042789A1 (en)	2006-09-29	2008-04-10	Ligocyte Pharmaceuticals, Inc.	Norovirus vaccine formulations
US20100266636A1 (en)	2007-09-18	2010-10-21	Ligocyte Pharmaceuticals, Inc.	Method of conferring a protective immune response to norovirus
US10130696B2 (en)	2007-09-18	2018-11-20	Takeda Vaccines, Inc.	Method of conferring a protective immune response to norovirus
CN108567975A (zh)	2011-07-11	2018-09-25	武田疫苗股份有限公司	胃肠外诺如病毒疫苗配制剂
JP2016533172A (ja)	2013-10-03	2016-10-27	タケダワクチン，インコーポレイテッド	細胞株からラブドウイルスを検出および除去する方法
JP6556632B2 (ja)	2013-12-16	2019-08-07	武田薬品工業株式会社	マイクロニードル
CN107184970A (zh) *	2017-02-16	2017-09-22	北京生物制品研究所有限责任公司	口服诺如病毒亚单位疫苗及lt作为该疫苗佐剂的用途
GB201703644D0 (en)	2017-03-07	2017-04-19	Elopak As	Improvements in or relating to toller mounting arrangements
KR20200003921A (ko) *	2017-05-15	2020-01-10	얀센 백신스 앤드 프리벤션 비.브이.	안정한 바이러스-함유 조성물
WO2019158653A1 (en) *	2018-02-15	2019-08-22	Icon Genetics Gmbh	Immunogenic composition and vaccine for generating an immune response to norovirus
WO2019231712A1 (en) *	2018-05-29	2019-12-05	Stc.Unm	Virus-like particle compositions and methods of using same
CN109265542B (zh) *	2018-09-27	2021-06-15	国药中生生物技术研究院有限公司	特异性结合诺如病毒gii.4基因型vp1蛋白或vlp的抗体及其制备方法和应用
AR117462A1 (es) *	2018-12-20	2021-08-04	Takeda Vaccines Inc	Vacuna contra norovirus, formulaciones y métodos
BR112022013537A2 (pt) *	2020-01-08	2022-11-22	Bharat Biotech Int Ltd	Composições de vacina viral e métodos de preparações das mesmas
AU2022248473B2 (en)	2021-03-29	2026-03-05	Denka Company Limited	Peptide of norovirus origin, polynucleotide, antibody, composition, method for identifying neutralizing epitope for norovirus
US20240238401A1 (en)	2021-05-21	2024-07-18	Takeda Vaccines, Inc.	Solid composition, freeze-drying method and glass vial
CN118252924A (zh) *	2022-12-27	2024-06-28	远大赛威信生命科学(南京)有限公司	用于诱发哺乳动物针对诺如病毒的免疫反应的药物组合物及其制备方法和用途
WO2025076792A1 (en) *	2023-10-12	2025-04-17	Chengdu Kanghua Biological Product Co., Ltd.	Methods of preparing norovirus vaccine with low amounts of adjuvant
WO2025077799A1 (en) *	2023-10-12	2025-04-17	Chengdu Kanghua Biological Products Co., Ltd.	Method of preparing norovirus vaccine without adjuvant

Family Cites Families (71)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6572862B1 (en)	1989-11-08	2003-06-03	Baylor College Of Medicine	Methods and reagents to detect and characterize Norwalk and related viruses
WO1992016543A1 (en)	1991-03-25	1992-10-01	Genelabs Incorporated	NORWALK VIRUS HUMAN GASTROENTERITIS AGENT AND MOLECULAR CLONING OF CORRESPONDING cDNAs
JPH07509122A (ja)	1992-04-08	1995-10-12	ザ　ガバメント　オブ　ザ　ユナイテッド　ステイツ　オブ　アメリカ，アズ　レプリゼンテッド　バイ　ザ　セクレター，デパートメント　オブ　ヘルス　アンド　ヒューマン　サービシーズ	野生型麻疹ウイルス糖タンパク質：ワクチンおよびその検出方法
JPH08500250A (ja)	1992-09-07	1996-01-16	ベイラー・カレッジ・オブ・メディシン	ノーウォークおよび関連ウイルスを検出し、かつ特徴付けるための方法並びに試薬
JP4028593B2 (ja)	1993-03-23	2007-12-26	グラクソスミスクライン・バイオロジカルス・ソシエテ・アノニム	３−ｏ脱アシル化モノホスホリルリピドａ含有ワクチン組成物
US5788970A (en)	1994-03-29	1998-08-04	The University Of Maryland College Park	Chimeric infectious bursal disease virus CDNA clones, expression products and vaccines based thereon
CA2189882C (en)	1994-05-16	2005-09-20	Kathrin U. Jansen	Papillomavirus vaccines
US5645051A (en)	1995-04-21	1997-07-08	Dura Pharmaceuticals, Inc.	Unit dose dry powder inhaler
US5861241A (en)	1995-08-16	1999-01-19	University Of Massachusetts	Monoclonal antibodies for detecting Norwalk virus
GB9525083D0 (en)	1995-12-07	1996-02-07	Danbiosyst Uk	Vaccine compositions
US5834015A (en) *	1996-09-11	1998-11-10	Albany Medical College	Protein-lipid vesicles and autogenous vaccine comprising the same
US5953727A (en)	1996-10-10	1999-09-14	Incyte Pharmaceuticals, Inc.	Project-based full-length biomolecular sequence database
US6491919B2 (en)	1997-04-01	2002-12-10	Corixa Corporation	Aqueous immunologic adjuvant compostions of monophosphoryl lipid A
PT973546E (pt)	1997-04-08	2004-06-30	Merck & Co Inc	Formulacoes estabilizadas de virus de papiloma humano
CA2288129A1 (en)	1997-05-01	1998-11-12	Chiron Corporation	Use of virus-like particles as adjuvants
US20040265377A1 (en)	1997-10-27	2004-12-30	Harry Seager	Solid dispersing vaccine composition for oral delivery
CN1354787A (zh)	1998-08-14	2002-06-19	麦克公司	纯化人乳头瘤病毒样颗粒的方法
EP1140161B1 (en)	1998-12-17	2006-04-19	Merck & Co., Inc.	Synthetic virus-like particles with heterologous epitopes
ES2313881T3 (es)	1999-02-05	2009-03-16	MERCK & CO., INC.	Formulaciones de vacunas frente al papilomavirus humano.
KR100771402B1 (ko)	1999-06-22	2007-10-30	국립감염증연구소장이 대표하는 일본국	Ｓｒｓｖ 검출 킷트
JP2002020399A (ja)	2000-07-10	2002-01-23	Osaka Prefecture	ノルウォークウイルス（ｎｖ）を認識するモノクローナル抗体
GB0118249D0 (en)	2001-07-26	2001-09-19	Chiron Spa	Histidine vaccines
WO2003068993A1 (en)	2002-02-14	2003-08-21	Novavax, Inc.	Method for isolation and purification of expressed gene products in vitro
GB0206360D0 (en)	2002-03-18	2002-05-01	Glaxosmithkline Biolog Sa	Viral antigens
GB0206359D0 (en)	2002-03-18	2002-05-01	Glaxosmithkline Biolog Sa	Viral antigens
EP1494651A4 (en)	2002-04-11	2010-10-13	Medimmune Vaccines Inc	PRESERVATION OF BIOACTIVE MATERIALS WITH FREEZZED FOAM
GB0302218D0 (en)	2003-01-30	2003-03-05	Chiron Sri	Vaccine formulation & Mucosal delivery
ATE521367T1 (de)	2002-06-07	2011-09-15	Kentucky Bioproc Llc	Flexlibler aufbau- und darreichungs-plattform von impfstoffen
AU2003242742B2 (en)	2002-06-20	2009-04-30	Cytos Biotechnology Ag	Packaged virus-like particles for use as adjuvants: method of preparation and use
JP4675317B2 (ja)	2003-01-30	2011-04-20	ノバルティスバクシンズアンドダイアグノスティックス，インコーポレーテッド	アジュバント化インフルエンザワクチン
JP2006518748A (ja)	2003-02-20	2006-08-17	ベクトン・ディキンソン・アンド・カンパニー	改良されたワクチン接種のための大気圧噴霧凍結乾燥によって作製される組換えブドウ球菌エンテロトキシンｂ（＜ｓｂ＞ｒ＜／ｓｂ＞ｓｅｂ）の粉末処方物
US8592197B2 (en)	2003-07-11	2013-11-26	Novavax, Inc.	Functional influenza virus-like particles (VLPs)
WO2005032457A2 (en)	2003-07-21	2005-04-14	Boyce Thompson Institute For Plant Research, Inc.	Vectors and methods for immunization against norwalk virus using transgenic plants
WO2005030806A2 (en)	2003-09-24	2005-04-07	Montana State University	Norovirus monoclonal antibodies and peptides
WO2005037223A2 (en)	2003-10-15	2005-04-28	Brigham And Women's Hospital, Inc.	Methods and compositions for immunomodulation
US20050215501A1 (en)	2003-10-24	2005-09-29	Coley Pharmaceutical Group, Inc.	Methods and products for enhancing epitope spreading
FR2863890B1 (fr)	2003-12-19	2006-03-24	Aventis Pasteur	Composition immunostimulante
US7481997B1 (en)	2004-02-12	2009-01-27	Montana State University	Snow mountain virus genome sequence, virus-like particles and methods of use
US20050260225A1 (en)	2004-05-18	2005-11-24	Goldberg Joanna B	Intranasal recombinant Salmonella vaccine encoding heterologous polysaccharide antigens
CU23496A1 (es)	2004-09-03	2010-02-23	Ct Ingenieria Genetica Biotech	Composición vacunal contra el virus de la hepatitis c
US8029802B2 (en)	2004-10-20	2011-10-04	Sanofi Pasteur Biologics Co.	Vaccines against Japanese encephalitis virus and West Nile virus
GB0428394D0 (en)	2004-12-24	2005-02-02	Chiron Srl	Saccharide conjugate vaccines
CA2593176A1 (en)	2005-01-05	2006-07-13	Peter D. Katsikis	Delivery vehicles, bioactive substances and viral vaccines
WO2006086188A2 (en)	2005-01-31	2006-08-17	The Johns Hopkins University	Use of consensus sequence as vaccine antigen to enhance recognition of virulent viral variants
DK1858919T3 (da)	2005-02-18	2012-07-16	Novartis Vaccines & Diagnostic	Immunogener fra uropathogen Escherichia coli
MX2007011160A (es)	2005-03-18	2007-11-13	Cytos Biotechnology Ag	Conjugados de alergenos de gato y usos de los mismos.
JP2009501001A (ja)	2005-06-01	2009-01-15	ダウグローバルテクノロジーズインコーポレイティド	多価ウイルス様粒子の製造
EP1736538A1 (en)	2005-06-21	2006-12-27	Cytos Biotechnology AG	Process for the preparative purification of virus-like-particles (VLPs)
CA2630220C (en)	2005-11-22	2020-10-13	Doris Coit	Norovirus and sapovirus antigens
JP2007145775A (ja)	2005-11-29	2007-06-14	Falco Life Science:Kk	ノロウイルスｇｉの高感度検出方法
US20080029915A1 (en) *	2006-08-02	2008-02-07	Courtoy Nv	Rotary tablet press
WO2008042789A1 (en)	2006-09-29	2008-04-10	Ligocyte Pharmaceuticals, Inc.	Norovirus vaccine formulations
EP2679240A1 (en)	2006-12-06	2014-01-01	Novartis AG	Vaccines including antigen from four strains of influenza virus
SG179488A1 (en) *	2007-03-14	2012-04-27	Ligocyte Pharmaceuticals Inc	Virus like particle purification
AU2008299589B2 (en)	2007-09-12	2014-06-26	Australian Centre For Plant Functional Genomics Pty Ltd	Plant seed active transcriptional control sequences
US10130696B2 (en) *	2007-09-18	2018-11-20	Takeda Vaccines, Inc.	Method of conferring a protective immune response to norovirus
US20100266636A1 (en)	2007-09-18	2010-10-21	Ligocyte Pharmaceuticals, Inc.	Method of conferring a protective immune response to norovirus
EP3382011A1 (en) *	2008-08-08	2018-10-03	Takeda Vaccines, Inc.	Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity
JP2012515752A (ja) *	2009-01-22	2012-07-12	ファーマシーネ，インコーポレイテッド	安定なワクチン組成物とその使用方法
EP2942062A1 (en) *	2009-02-10	2015-11-11	Novartis AG	Influenza vaccine regimens for pandemic-associated strains
US20110070260A1 (en)	2009-09-09	2011-03-24	Baric Ralph S	Multivalent Immunogenic Compositions Against Noroviruses and Methods of Use
US8980275B2 (en)	2010-01-21	2015-03-17	Takeda Vaccines, Inc.	Targeted heterologous antigen presentation on calicivirus virus-like particles
US20110293723A1 (en) *	2010-05-26	2011-12-01	Selecta Biosciences, Inc.	Synthetic nanocarrier combination vaccines
CN108567975A (zh)	2011-07-11	2018-09-25	武田疫苗股份有限公司	胃肠外诺如病毒疫苗配制剂
JOP20130186B1 (ar)	2012-06-22	2021-08-17	Takeda Vaccines Montana Inc	تنقية الجزيئات الشبيهة بالفيروسات
JP2019505498A (ja)	2015-12-16	2019-02-28	ザ・ウォルター・アンド・エリザ・ホール・インスティテュート・オブ・メディカル・リサーチ	Ｎｋ細胞におけるサイトカイン誘導性ｓｈ２タンパク質の阻害
EP4338799A3 (en)	2016-10-18	2024-06-05	Regents of the University of Minnesota	Tumor infiltrating lymphocytes and methods of therapy
AU2019262218B2 (en)	2018-05-03	2025-04-24	Board Of Regents, The University Of Texas System	Natural killer cells engineered to express chimeric antigen receptors with immune checkpoint blockade
JP2021534074A (ja)	2018-08-20	2021-12-09	タケダワクチン, インコーポレイテッドTakeda Vaccines, Inc.	Ｖｌｐ製剤
AR117462A1 (es)	2018-12-20	2021-08-04	Takeda Vaccines Inc	Vacuna contra norovirus, formulaciones y métodos
KR20210129105A (ko)	2019-02-15	2021-10-27	에디타스 메디신, 인코포레이티드	면역치료법을 위한 변형된 자연 살해(nk) 세포

2012
- 2012-07-11 CN CN201810373895.1A patent/CN108567975A/zh active Pending
- 2012-07-11 KR KR1020147003571A patent/KR102096937B1/ko active Active
- 2012-07-11 JP JP2014520273A patent/JP6208659B2/ja active Active
- 2012-07-11 CN CN201510262891.2A patent/CN105031637A/zh active Pending
- 2012-07-11 CN CN201280043691.2A patent/CN103874507A/zh active Pending
- 2012-07-11 PH PH1/2021/551773A patent/PH12021551773A1/en unknown
- 2012-07-11 WO PCT/US2012/046222 patent/WO2013009849A1/en not_active Ceased
- 2012-07-11 DK DK17199372.8T patent/DK3299030T3/da active
- 2012-07-11 PH PH1/2014/500093A patent/PH12014500093A1/en unknown
- 2012-07-11 SG SG10201605644WA patent/SG10201605644WA/en unknown
- 2012-07-11 MX MX2018006816A patent/MX379496B/es unknown
- 2012-07-11 EA EA201490258A patent/EA029470B1/ru not_active IP Right Cessation
- 2012-07-11 EA EA202090699A patent/EA202090699A3/ru unknown
- 2012-07-11 AU AU2012282658A patent/AU2012282658B2/en active Active
- 2012-07-11 CA CA2841356A patent/CA2841356C/en active Active
- 2012-07-11 PL PL17199372.8T patent/PL3299030T3/pl unknown
- 2012-07-11 ES ES12811916.1T patent/ES2656527T3/es active Active
- 2012-07-11 CR CR20190540A patent/CR20190540A/es unknown
- 2012-07-11 HK HK14112697.5A patent/HK1199202A1/xx unknown
- 2012-07-11 EP EP22176978.9A patent/EP4112074A1/en active Pending
- 2012-07-11 GE GEAP201213384A patent/GEP201706668B/en unknown
- 2012-07-11 PL PL12811916T patent/PL2731621T3/pl unknown
- 2012-07-11 EA EA201792407A patent/EA035442B1/ru not_active IP Right Cessation
- 2012-07-11 ES ES17199372T patent/ES2926487T3/es active Active
- 2012-07-11 EP EP12811916.1A patent/EP2731621B1/en active Active
- 2012-07-11 MY MYPI2014000073A patent/MY170746A/en unknown
- 2012-07-11 PE PE2014000054A patent/PE20140845A1/es active IP Right Grant
- 2012-07-11 EP EP17199372.8A patent/EP3299030B1/en active Active
- 2012-07-11 MX MX2014000411A patent/MX356586B/es active IP Right Grant
- 2012-07-11 BR BR112014000656A patent/BR112014000656A2/pt not_active Application Discontinuation
- 2012-11-07 UA UAA201401321A patent/UA117732C2/uk unknown
2013
- 2013-03-15 US US13/840,403 patent/US9801934B2/en active Active
2014
- 2014-01-07 TN TNP2014000008A patent/TN2014000008A1/en unknown
- 2014-01-07 IL IL230356A patent/IL230356B/en active IP Right Grant
- 2014-01-10 CL CL2014000082A patent/CL2014000082A1/es unknown
- 2014-01-10 DO DO2014000004A patent/DOP2014000004A/es unknown
- 2014-02-06 MA MA36741A patent/MA35414B1/fr unknown
- 2014-02-10 ZA ZA2014/01012A patent/ZA201401012B/en unknown
- 2014-02-11 CR CR20140069A patent/CR20140069A/es unknown
- 2014-02-11 EC ECSP14013201 patent/ECSP14013201A/es unknown
- 2014-12-18 HK HK16102061.2A patent/HK1215154A1/zh unknown
2015
- 2015-02-09 ZA ZA2015/00915A patent/ZA201500915B/en unknown
- 2015-02-19 AU AU2015200836A patent/AU2015200836B2/en active Active
- 2015-07-10 US US14/796,614 patent/US9867876B2/en active Active
2017
- 2017-05-02 JP JP2017091755A patent/JP6613259B2/ja active Active
- 2017-12-08 US US15/836,030 patent/US10675341B2/en active Active
2018
- 2018-07-06 PH PH12018501515A patent/PH12018501515B1/en unknown
2020
- 2020-06-05 US US16/894,291 patent/US11701420B2/en active Active
2022
- 2022-02-04 DO DO2022000030A patent/DOP2022000030A/es unknown
2023
- 2023-05-24 US US18/322,679 patent/US20230338503A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EA201490258A1 (ru)	2014-05-30
NZ620865A (en)	2015-08-28
PH12018501515A1 (en)	2019-02-04
EA201792407A3 (ru)	2018-07-31
DOP2014000004A (es)	2014-10-31
MA35414B1 (fr)	2014-09-01
CR20140069A (es)	2014-06-27
HK1199202A1 (en)	2015-06-26
ZA201500915B (en)	2016-06-29
JP2014520852A (ja)	2014-08-25
PH12021551773A1 (en)	2022-08-01
US9867876B2 (en)	2018-01-16
JP2017214357A (ja)	2017-12-07
PL2731621T3 (pl)	2018-10-31
EA202090699A3 (ru)	2020-11-30
SG10201605644WA (en)	2016-09-29
CN103874507A (zh)	2014-06-18
AU2012282658A1 (en)	2013-03-14
DOP2022000030A (es)	2022-06-30
EP2731621B1 (en)	2017-11-01
PH12014500093A1 (en)	2014-03-17
EP3299030B1 (en)	2022-06-08
AU2015200836A1 (en)	2015-03-12
JP6613259B2 (ja)	2019-11-27
AU2015200836B2 (en)	2016-08-25
EP2731621A1 (en)	2014-05-21
MX356586B (es)	2018-06-05
US20230338503A1 (en)	2023-10-26
CR20190540A (es)	2022-04-04
AU2012282658B2 (en)	2014-11-27
CL2014000082A1 (es)	2014-07-04
US20130273102A1 (en)	2013-10-17
US9801934B2 (en)	2017-10-31
US10675341B2 (en)	2020-06-09
BR112014000656A2 (pt)	2017-02-14
ZA201401012B (en)	2015-05-27
CN105031637A (zh)	2015-11-11
NZ710919A (en)	2017-12-22
TN2014000008A1 (en)	2015-07-01
EP4112074A1 (en)	2023-01-04
MY170746A (en)	2019-08-27
EA035442B1 (ru)	2020-06-17
EP2731621A4 (en)	2015-03-25
HK1215154A1 (zh)	2016-08-19
US11701420B2 (en)	2023-07-18
MX2014000411A (es)	2014-08-26
WO2013009849A1 (en)	2013-01-17
US20210085778A1 (en)	2021-03-25
ES2656527T3 (es)	2018-02-27
ECSP14013201A (es)	2014-05-31
EA202090699A2 (ru)	2020-07-31
GEP201706668B (en)	2017-05-25
US20180185468A1 (en)	2018-07-05
MX379496B (es)	2025-03-11
PL3299030T3 (pl)	2022-12-05
PE20140845A1 (es)	2014-08-03
CA2841356C (en)	2022-03-01
IL230356B (en)	2019-05-30
UA117732C2 (uk)	2018-09-25
EP3299030A1 (en)	2018-03-28
KR20140066160A (ko)	2014-05-30
CA2841356A1 (en)	2013-01-17
CN108567975A (zh)	2018-09-25
HK1198136A1 (en)	2015-03-13
PH12018501515B1 (en)	2022-02-18
EA201792407A2 (ru)	2018-03-30
ES2926487T3 (es)	2022-10-26
JP6208659B2 (ja)	2017-10-04
EA029470B1 (ru)	2018-03-30
KR102096937B1 (ko)	2020-04-03
US20160000899A1 (en)	2016-01-07

Publication	Publication Date	Title
DK3299030T3 (da)	2022-09-05	Parenterale norovirus-vaccineformuleringer
PL2684880T3 (pl)	2018-07-31	Pochodna dispiropirolidyny
DK2744810T4 (da)	2023-11-20	Tenofovir-alafenamid-hemifumarat
EP2748500A4 (en)	2014-12-10	BRACKET
EP2673344A4 (en)	2016-08-17	STABLE BIO OIL
DK2769050T3 (da)	2021-05-17	Propsensor
DE102011100082A8 (de)	2013-01-10	Traygreifvorrichtung
EP2789316A4 (en)	2015-08-12	CARRIER
DK2673539T3 (da)	2019-10-21	Rør
BR112014000879A2 (pt)	2017-02-21	deflegmador
CO6960543A2 (es)	2014-05-30	2-tiopirimidinonas
BR112014005756A2 (pt)	2017-03-28	vacina
EP2800129A4 (en)	2015-07-08	CONNECTION STRUCTURE
EP2690041A4 (en)	2014-09-03	LONG MEDIUM
FI20116167L (fi)	2012-12-11	Järjestely
IL231660A0 (en)	2014-05-28	Composition
PL2762466T3 (pl)	2017-09-29	Pochodna fenylu
FR2975564B1 (fr)	2014-09-12	Charrue
DE112011104936A5 (de)	2013-11-28	Stanzstauchniet
EP2763699A4 (en)	2015-05-20	VACCINE
HRP20181667T1 (hr)	2018-12-14	Pripravak
DK2672817T3 (da)	2017-11-20	Forbedrede insekticide formuleringer
DE112012000958A5 (de)	2013-11-28	Handsäge
DK2476953T3 (da)	2020-05-11	Fluidbedkedel
DE112012002458A5 (de)	2014-02-27	Hydrotransformator